CLINICAL_TRIALS
trial_result
· 2012-01-30
Clinical Trial Update: A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081) [Phase 1]
Summary
Phase 1 study in adolescents evaluated the pharmacokinetics, safety and tolerability of sitagliptin for type 2 diabetes. Results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2012-01-30